Hereditary Kidney Cancer Syndromes

Kidney Cancer ◽  
2015 ◽  
pp. 123-133
Author(s):  
Shu Pan ◽  
Brian Shuch
2014 ◽  
Vol 191 (4S) ◽  
Author(s):  
Kelly Stratton ◽  
Shaheen Alanee ◽  
Emily Glogowski ◽  
Kasmintan Schrader ◽  
Rohini Rau-Murthy ◽  
...  

Author(s):  
Mariam Jafri ◽  
Eamonn R Maher

Renal cell carcinoma (RCC) is the exemplar of how the understanding of the molecular pathogenesis of rare inherited disorders can inform an understanding of the key pathways involved in the pathogenesis of sporadic cancer. In this chapter we describe the clinical and pathological features of the inherited kidney cancer syndromes: von Hippel Lindau disease (VHL); Birt-Hogg-Dube syndrome; hereditary leiomyomatosis and renal cancer syndrome; succinate dehydrogenase disorders; hereditary papillary renal cancer; and translocation-associated kidney cancer. Though individually rare, recognition of individuals with familial kidney cancer is important as they present specific clinical challenges to the urological surgeon because of their propensity to develop multicentric/bilateral tumours. Furthermore, different familial RCC predisposition syndromes are associated with different extra renal clinical features and have specific surveillance needs. Despite differences in clinical features, there is some overlap in the molecular pathophysiology between the disorders and these highlight the key signalling pathways for RCC oncogenesis.


2014 ◽  
Vol 12 (9) ◽  
pp. 1347-1355 ◽  
Author(s):  
Thai H. Ho ◽  
Eric Jonasch

2016 ◽  
Vol 34 (5) ◽  
pp. 238.e1-238.e7 ◽  
Author(s):  
Kelly L. Stratton ◽  
Shaheen Alanee ◽  
Emily A. Glogowski ◽  
Kasmintan A. Schrader ◽  
Rohini Rau-Murthy ◽  
...  

2012 ◽  
Vol 1 (2S) ◽  
Author(s):  
Darwin L. Lim ◽  
Raymond Ko ◽  
Stephen E. Pautler

Renal cell carcinoma (RCC), the fifth leading malignant condition for menand tenth for women, accounts for 3% of all malignancies in Canada. It is aheterogeneous epithelial malignancy with different subtypes and varied tumourbiology. Although most cases of RCC are sporadic, up to 4% of patients havean inherited predisposition for the disease. In this article, we review the currentmolecular genetics of the different subtypes in hereditary and sporadic RCC. Significant developments in understanding the underlying genetic basis of RCC over the last 2 decades are attributed to intensive research about rareinherited renal cancer syndromes and the identification of the genes responsiblefor them. Many of these genes are also found in sporadic RCC. Understanding the molecular mechanisms involved in the pathogenesis of RCC has aided the development of molecular-targeted drugs for this disease.


2014 ◽  
Vol 21 (1) ◽  
pp. 81-90 ◽  
Author(s):  
Naomi B. Haas ◽  
Katherine L. Nathanson

2019 ◽  
Vol 39 (3) ◽  
pp. 141
Author(s):  
Cindy Curry ◽  
Kelly Ernst

Sign in / Sign up

Export Citation Format

Share Document